Latest Developments in Birth Control

Not long ago, effective birth control was limited to just a few options. Now, it includes everything from patches to an updated rhythm method and there are more changes on the horizon. The FDA is currently debating the rules for selling the morning-after pill. Neal Conan and guests discuss the latest developments in contraception.


Otesa Middleton
*Dow Jones Newswires reporter covering the FDA
*Attending the hearing on the morning-after pill at the Gaithersburg Hilton

Andrea Tone
*Author of Devices and Desires: A History of Contraceptives in America
*Professor in the School of History, Technology and Society at Georgia Tech

Dr. Robert Hatcher
*Author of textbooks on contraception: Contraceptive Technology and Managing Contraception
*Professor of obstetrics and gynecology, Emory University

Victoria Jennings
*Director, Georgetown Institute for Reproductive Health
*Co-developer of "Standard-Days" method and cyclebeads (updated rhythm method)

Copyright © 2003 NPR. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.

Copyright © 2003 NPR. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to NPR. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.



Please keep your community civil. All comments must follow the Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.